In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

ContraVir Pharmaceuticals Inc. Trade Record

NASDAQ:CTRV ContraVir Pharmaceuticals Inc stock gains 7.38% Exit Oct 19, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CTRV Oct 18, 2018, priceSeries
About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. ContraVir Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Edison, New Jersey.

Trade Information
Trade Type
Entry Date
Oct 18, 2018
Entry Price
Sell Date
Oct 19, 2018
Sell Price
Net Gain
Hold Time
1 Trading Days